Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v2.4.0.6
Consolidated Balance Sheet (Parenthetical) (USD $)
In Millions, except Share data, unless otherwise specified
Sep. 30, 2012
Dec. 31, 2011
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell, measured at fair value $ 104,494 $ 87,453
Trading account assets, pledged as collateral 103,208 80,130
Debt securities:    
Available-for-sale, pledged as collateral 52,561 69,021
Held-to-maturity, at cost, fair value 41,128 35,442
Held-to-maturity Securities Pledged as Collateral 12,995 24,009
Loans and leases, measured at fair value 7,638 8,804
Loans and leases, pledged as collateral 46,657 73,463
Mortgage servicing rights 5,087 7,378
Loans held-for-sale, measured at fair value 11,077 7,630
Other Assets 32,552 37,084
Deposits in U.S. offices:    
Interest-bearing, measured at fair value 2,449 3,297
Federal funds purchased and securities loaned or sold under agreements to repurchase 53,635 34,235
Commercial paper and other short-term borrowings, measured at fair value 4,278 6,558
Accrued expenses and other liabilities, measured at fair value 18,280 15,743
Accrued expenses and other liabilities, reserve for unfunded lending commitments 518 714
Long-term debt, measured at fair value 49,912 46,239
Shareholders' equity    
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, authorized shares 100,000,000 100,000,000
Preferred stock, issued shares 3,685,410 3,689,084
Preferred stock, outstanding shares 3,685,410 3,689,084
Common stock, par value $ 0.01 $ 0.01
Common stock, authorized shares 12,800,000,000 12,800,000,000
Common stock, issued shares 10,777,267,465 10,535,937,957
Common stock, outstanding shares 10,777,267,465 10,535,937,957
Consolidated VIEs [Member] | Short-term Debt [Member]
    
Shareholders' equity    
Non-recourse debt 1,111 650
Consolidated VIEs [Member] | Long-term debt
    
Shareholders' equity    
Non-recourse debt 33,285 44,976
Consolidated VIEs [Member] | Other Liabilities
    
Shareholders' equity    
Non-recourse debt $ 145 $ 225